David B. Yaden (@ExistWell) header
David B. Yaden (@ExistWell) profile picture

Associate Professor at @HopkinsMedicine; PhD; Science of psychedelics and other altered states of consciousness @TheYadenLab @JHPsychedelics @psychedelethics

Johns Hopkins University
Joined February 2009
Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)Photo by David B. Yaden (@ExistWell)
David B. Yaden retweeted
This is an unusual & interesting survey in this space, and I invite you to take it. The idea emerged at a @psychedelethics meeting at Oxford when the group realized we don't have data on what groups in the field think should received more funding/attention. Share your ideas!
🍄 @JHPsychedelics PSYCHEDELIC STAKEHOLDER SURVEY 🔬 There are more promising psychedelic research projects than there is funding. What should take priority? Our new survey is open to anyone with a personal or professional interest in psychedelic science [link below]
1
6
19
906
David B. Yaden retweeted
"Safety in an Evolving Psychedelic Landscape: Knowledge and Use of Psilocybin Safety Strategies, Resources, and Support in a Naturalistic Oregon Sample" sciencedirect.com/science/ar…
1
3
6
361
David B. Yaden retweeted
In particular, many websites advertised possible medical and non-medical benefits of psilocybin services, raising questions about how online advertising, especially related to medical applications, may shape public expectations of psilocybin services.
2
1
6
194
David B. Yaden retweeted
We analyzed claims made in service centers' websites, and found substantial variation in how centers described psilocybin's benefits, risks, mechanisms, evidence base, and legal status.
1
1
6
188
David B. Yaden retweeted
With early data from the Oregon Health Authority showing that clients report seeking out psilocybin services in Oregon for a wide range of motivations, one question is how service centers are representing their services to the public.
1
8
2
13
653
Join us Wednesday, November 18, 2026 at 4:30pm ET for the Psychedelic Archives Project guest speaker series, featuring Dr. Arielle Saiber, presenting “The Spatial Phenomenology of Altered States of Consciousness”. Join on this Zoom link: JHUBlueJays.zoom.us/j/926229…
1
6
1
20
1,643
This is an important initiative to find out what the research priorities should be in relation to psychedelics over the coming years - if you're a stakeholder please fill this out!
🍄 @JHPsychedelics PSYCHEDELIC STAKEHOLDER SURVEY 🔬 There are more promising psychedelic research projects than there is funding. What should take priority? Our new survey is open to anyone with a personal or professional interest in psychedelic science [link below]
1
3
5
743
David B. Yaden retweeted
I made a little visualisation to try and help explain p-values for students. Some people might enjoy: psy104-p-values.netlify.app/
4
21
154
9,917
David B. Yaden retweeted
The first completely on-site preclinical animal study from @JHPsychedelics. An immensely valuable collaboration with Division of Behavioral Biology. So grateful that I got to lead it and work with what can only be called the dream team! Unroll the tweet below for deets 📜
New paper led by @PraachiTiwari, a former postdoc in @TheYadenLab, now faculty at Div of Behavioral Bio & @JHPsychedelics (also w/ @CassieMoorePhD, Brian Jenkins, Elise Weerts, me). We examined how psilocybin affects a broader range of spontaneous behaviors in rats than HTR...
8
19
1,573
David B. Yaden retweeted
What are your priorities for future psychedelic research? Researchers at Johns Hopkins are interested in hearing from psychedelic researchers, entrepreneurs, trial participants, mental health professionals, and anyone with a personal or professional interest in psychedelic science. Fill in the survey here: psychedelicsurvey2026.com/
4
1
10
1,451
Dr. David Yaden spoke on a panel that brought together scientific, policy, and legal perspectives on psychedelic treatment at Yale Law School’s Solomon Center for Health Law and Policy, reviewing what the science can and cannot yet tell us, including how to weigh their risks and benefits. law.yale.edu/yls-today/news/…
1
6
14
1,148
On most philosophical thought experiments, people give different answers. Say 60% of people choose answer A, 40% choose B Here’s one picture of what’s happening: There's something about each individual person that gives them a 60% chance of choosing A, 40% chance of choosing B
1
9
1
26
1,771
David B. Yaden retweeted
Replying to @bita137
@bita137 I await the results of these studies before making any inferences about psychedelic drug actions in humans...
3
4
3
36
4,835
David B. Yaden retweeted
It was a joy to read (and write about) this new book by @TaniaLombrozo, whose work I have followed since I was an undergraduate! Tania is a role model to so many of us with interdisciplinary interests across philosophy and psychology, and this book illustrates why 👇
Review of WHY WE ASK WHY in Science, written by @chazfirestone, who does an amazing job extracting and clearly explaining several core ideas from the book in a single, beautifully written page science.org/doi/10.1126/scie…
4
21
1,432
David B. Yaden retweeted
Review of WHY WE ASK WHY in Science, written by @chazfirestone, who does an amazing job extracting and clearly explaining several core ideas from the book in a single, beautifully written page science.org/doi/10.1126/scie…
1
12
2
60
5,007
🍄 @JHPsychedelics PSYCHEDELIC STAKEHOLDER SURVEY 🔬 There are more promising psychedelic research projects than there is funding. What should take priority? Our new survey is open to anyone with a personal or professional interest in psychedelic science [link below]
4
21
2
28
3,230
David B. Yaden retweeted
📣 Check out these results and more in our new Psychopharmacology article: link.springer.com/article/10…
1
1
6
279